Additional recommendations for use of tetanus toxoid, reduced-content diphtheria toxoid, and acellular pertussis vaccine (Tdap)

Pediatrics

Volumn 128, Issue 4, 2011, Pages 809-812

  Brady, Michael T ^a   Byington, Carrie L ^a   Davies, H Dele ^a   Edwards, Kathryn M ^a   Glode, Mary P ^a   Jackson, Mary Anne ^a   Keyserling, Harry L ^a   Maldonado, Yvonne A ^a   Murray, Dennis L ^a   Orenstein, Walter A ^a   Schutze, Gordon E ^a   Willoughby, Rodney E ^a   Zaoutis, Theoklis E ^a  

^a NONE

Author keywords

Adolescents; Adults; Diphtheria; Infants; Pertussis; Tdap vaccine; Tetanus

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE;

BRAIN DISEASE; CRANIAL NEUROPATHY; DIPHTHERIA; DISEASE SEVERITY; DRUG SAFETY; DRUG USE; ENCEPHALITIS; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNIZATION; IMMUNOGENICITY; INFECTION PREVENTION; INFECTION SENSITIVITY; MENINGITIS; PARALYSIS; PERTUSSIS; PRIORITY JOURNAL; SEIZURE; SHORT SURVEY; SINGLE DRUG DOSE; TETANUS;

AGED; CHILD; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; HEALTH POLICY; HUMANS; INFANT; UNITED STATES;

EID: 80053492337     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2011-1752     Document Type: Short Survey

References (13)

1. American Academy of Pediatrics, Committee on Infectious Diseases. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. Pediatrics. 2006;117(3): 965-977
2. Kretsinger K, Broder KR, Cortese MM, et al Centers for Disease Control and Prevention, Advisory Committee on Immunization Practices, Healthcare Infection Control Practices Advisory Committee. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm Rep. 2006;55(RR- 17):1-33
3. Centers for Disease Control and Prevention. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010. MMWR Morbid Mortal Wkly Rep. 2011;60(1):13-15
4. American Academy of Pediatrics. Pertussis. In: Pickering LK, Baker CJ, Kimberlin DW, Long SS, eds. Red Book: 2009 Report of the Committee on Infectious Diseases. 28th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2009:504-519
5. Murphy TV, Slade BA, Broder KR, et al Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention. Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008;57(RR-4):1-51
6. Halperin SA, Sweet L, Baxendale D, et al. How soon after a prior tetanus-diphtheria vaccination can one give adult formulation tetanus-diphtheria-acellular pertussis vaccine? Pediatr Infect Dis J. 2006;25(3): 195-200 (Pubitemid 43379057)
7. Beytout J, Launay O, Guiso N, et al. Safety of Tdap-IPV given 1 month after Td-IPV booster in healthy young adults: a placebo controlled trial. Hum Vaccin. 2009;5(5):315-321
8. Talbot EA, Brown KH, Kirkland KB, Baughman AL, Halperin SA, Broder KP. The safety of immunizing with tetanus-diphtheriaacellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: experience during a mass vaccination campaign of healthcare personnel during a respiratory illness outbreak. Vaccine. 2010;28(50):8001- 8007
9. Jackson LA, Yu O, Nelson J, et al. Risk of medically attended local reactions following diphtheria toxoid containing vaccines in adolescents and young adults: a Vaccine Safety Datalink study. Vaccine. 2009;27(36): 4912-4916
10. Yih WK, Nordin JD, Kulldorff M, et al. An assessment of the safety of adolescent and adult tetanus-diphtheria-acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety Datalink. Vaccine. 2009;27(32):4257-4262
11. Langley JM, Predy G, Guasparini R, et al. An adolescent-adult formulation tetanus and diphtheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine. Vaccine. 2007;25(6):1121-1125 (Pubitemid 44937444)
12. Meyer CU, Habermehl P, Knuf M, Hoet B, Wolter J, Zepp F. Immunogenicity and reactogenicity of acellular pertussis booster vaccines in children: standard pediatric versus a reduced-antigen content formulation. Hum Vaccin. 2008;4(3):203-209
13. Scheifele DW, Halperin SA, Ochnio JJ, Ferguson AC, Skowronski DM. A modified vaccine reduces the rate of large injection site reactions to the preschool booster dose of diphtheria-tetanus-acellular pertussis vaccine: results of a randomized, controlled trial. Pediatr Infect Dis J. 2005;24(12): 1059-1066 (Pubitemid 43011060)